Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06877507

Rapid Diagnostic Technology for AUGIB Based on Analysis of VOCs in Exhaled Breath

Rapid Diagnostic Technology for Acute Upper Gastrointestinal Bleeding Based on Analysis of Volatile Organic Compounds (VOCs) in Exhaled Breath

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Beijing 302 Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study aims to develop a non-invasive and rapid diagnostic technology for acute upper gastrointestinal bleeding (AUGIB) by analyzing volatile organic compounds (VOCs) in exhaled breath. Clinically confirmed patients will be divided into three groups (no bleeding, minor bleeding, major bleeding) based on endoscopic findings. VOC profiles will be analyzed to construct a predictive model, validated for sensitivity and specificity (both targets ≥0.7). This approach addresses the limitations of endoscopy in emergency or resource-limited settings, improving diagnostic efficiency and reducing mortality.

Detailed description

Acute upper gastrointestinal bleeding (AUGIB) is a common emergency with an annual incidence of 100-180/100,000 and mortality of 2%-15%. Endoscopy, the gold standard, is invasive and equipment-dependent, limiting its use in primary care or emergencies. Exhaled breath VOCs analysis, a non-invasive and portable method, has been applied in other diseases but not yet explored for AUGIB. Objectives: 1. Identify characteristic VOC profiles in exhaled breath of AUGIB patients. 2. Develop a VOC-based predictive model with sensitivity and specificity ≥0.7. 3. Establish rapid diagnostic criteria to enhance clinical decision-making.

Conditions

Interventions

TypeNameDescription
DEVICEGastroscopyGastroscopy for all included patients
DIAGNOSTIC_TESTGas Chromatography - Mass SpectrometryUsing a patient's exhaled breath test with Gas Chromatography - Mass Spectrometry

Timeline

Start date
2025-03-20
Primary completion
2025-07-20
Completion
2025-07-20
First posted
2025-03-14
Last updated
2025-03-14

Source: ClinicalTrials.gov record NCT06877507. Inclusion in this directory is not an endorsement.